facioscapulohumeral


Also found in: Acronyms.

facioscapulohumeral

 [fa″she-o-skap″u-lo-hu´mer-al]
pertaining to the face, scapula, and arm.

facioscapulohumeral

Referring to the face, shoulder and arm.

facioscapulohumeral

(fā″shē-ō-skăp″ū-lō-hū′mĕr-ăl) [″ + scapula, shoulder blade, + humerus, shoulder]
Pert. to the face, scapula, and upper arm.
References in periodicals archive ?
Acceleron is developing ACE-083 for diseases such as facioscapulohumeral dystrophy and Charcot-Marie-Tooth disease, in which improved muscle strength in target muscles may provide a clinical benefit and enhance quality of life.
Germline mosaicsm in 4q35 facioscapulohumeral muscular dystrophy (FSHD1A) occurring predominately in oogenesis.
Facioscapulohumeral muscular dystrophy (FSHD) is an inherited myopathy characterised by progressive muscle weakness and wasting.
For instance, we can make use of the Human Disease Ontology [38] term has_symptom to establish the connection between a Facioscapulohumeral Muscular Dystrophy (FSHD) patient and the identified symptoms: coeus:Patient_X doid:has_symptom obo:HP.0001324 (i.e., muscle weakness.).
We examined the safety and effectiveness of a low dose of analog granulocyte-colony stimulating factor in a 15-year-old boy with facioscapulohumeral dystrophy.
Diagnosed with facioscapulohumeral (FSH) muscular dystrophy, aged five, Laura has spoken out against the under-representation of disabled people in the fashion industry.
In a published study, scientists from Genea Biocells analyzed in detail cellular and molecular aspects of facioscapulohumeral muscular dystrophy (FSHD) during myogenic development and in myotube cultures by comparing muscle cells generated from five FSHD-affected and four normal control stem cell lines.
*** Facioscapulohumeral,limb-girdle, oculopharyngeal, distal, and myofibrilla
Their topics include the multifaceted role of YY1 in establishing the cellular epigenetic landscape, identifying mammalian proteins involved in epigenetics, the diverse roles of long non-coding RNA in regulatory processes, the long and short of facioscapulohumeral muscular dystrophy, the environment and the epigenetic transgenerational inheritance of disease, and metabolic inputs into epigenetics.
Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral dystrophy.